CIK 0001850119 · <br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP Finance & Operations acquired 17,007 shares (grant or award)
- 4 Planned sale See Remarks sold 5,000 shares at $3.00 ($14,989)
- 4 Planned sale See Remarks sold 5,000 shares at $3.00 ($14,978)
- 4 Planned sale See Remarks sold 5,000 shares at $3.12 ($15,619)
- 4 Open-market sale SVP Finance & Operations sold 257 shares at $3.11 ($798)
- 4 Open-market sale Chief Operations Officer sold 913 shares at $3.11 ($2,836)
- 4 Planned sale See Remarks sold 5,000 shares at $3.10 ($15,490)
- 4 Grant or award President and CEO acquired 17,425 shares (grant or award)
- 4 Grant or award SVP Finance & Operations acquired 14,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 24,000 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 24,000 shares (grant or award)
- 4 Grant or award President of R&D acquired 24,000 shares (grant or award)
- 4 Open-market sale Chief Operations Officer sold 53,515 shares at an average $5.04 ($269,682)
- 4 Open-market sale Chief Operations Officer sold 485 shares at $4.86 ($2,358)
- 4 Open-market sale SVP Finance & Operations sold 1,200 shares at an average $4.14 ($4,969)
- 4 Open-market sale Chief Operations Officer sold 3,819 shares at an average $4.14 ($15,821)
- 4 Grant or award President and CEO acquired 1,453,279 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 6 of 10 · 188 filings